MORABITO, ANGELA
MORABITO, ANGELA
Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] (Annals of Oncology (2022) 33(57-66) (S0923753421044963), (10.1016/j.annonc.2021.09.017))
2022-01-01 Novello, S.; Torri, V.; Grohe, C.; Kurz, S.; Serke, M.; Wehler, T.; Meyer, A.; Ladage, D.; Geissler, M.; Colantonio, I.; Cauchi, C.; Stoelben, E.; Ceribelli, A.; Kropf-Sanchen, C.; Valmadre, G.; Borra, G.; Schena, M.; Morabito, A.; Santo, A.; Gregorc, V.; Chiari, R.; Reck, M.; Schmid-Bindert, G.; Folprecht, G.; Griesinger, F.; Follador, A.; Pedrazzoli, P.; Bearz, A.; Caffo, O.; Dickgreber, N. J.; Irtelli, L.; Wiest, G.; Monica, V.; Porcu, L.; Manegold, C.; Scagliotti, G. V.
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
2022-01-01 Novello, S.; Torri, V.; Grohe, C.; Kurz, S.; Serke, M.; Wehler, T.; Meyer, A.; Ladage, D.; Geissler, M.; Colantonio, I.; Cauchi, C.; Stoelben, E.; Ceribelli, A.; Kropf-Sanchen, C.; Valmadre, G.; Borra, G.; Schena, M.; Morabito, A.; Santo, A.; Gregorc, V.; Chiari, R.; Reck, M.; Schmid-Bindert, G.; Folprecht, G.; Griesinger, F.; Follador, A.; Pedrazzoli, P.; Bearz, A.; Caffo, O.; Dickgreber, N. J.; Irtelli, L.; Wiest, G.; Monica, V.; Porcu, L.; Manegold, C.; Scagliotti, G. V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] (Annals of Oncology (2022) 33(57-66) (S0923753421044963), (10.1016/j.annonc.2021.09.017)) | 1-gen-2022 | Novello, S.; Torri, V.; Grohe, C.; Kurz, S.; Serke, M.; Wehler, T.; Meyer, A.; Ladage, D.; Geissler, M.; Colantonio, I.; Cauchi, C.; Stoelben, E.; Ceribelli, A.; Kropf-Sanchen, C.; Valmadre, G.; Borra, G.; Schena, M.; Morabito, A.; Santo, A.; Gregorc, V.; Chiari, R.; Reck, M.; Schmid-Bindert, G.; Folprecht, G.; Griesinger, F.; Follador, A.; Pedrazzoli, P.; Bearz, A.; Caffo, O.; Dickgreber, N. J.; Irtelli, L.; Wiest, G.; Monica, V.; Porcu, L.; Manegold, C.; Scagliotti, G. V. | |
| International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer | 1-gen-2022 | Novello, S.; Torri, V.; Grohe, C.; Kurz, S.; Serke, M.; Wehler, T.; Meyer, A.; Ladage, D.; Geissler, M.; Colantonio, I.; Cauchi, C.; Stoelben, E.; Ceribelli, A.; Kropf-Sanchen, C.; Valmadre, G.; Borra, G.; Schena, M.; Morabito, A.; Santo, A.; Gregorc, V.; Chiari, R.; Reck, M.; Schmid-Bindert, G.; Folprecht, G.; Griesinger, F.; Follador, A.; Pedrazzoli, P.; Bearz, A.; Caffo, O.; Dickgreber, N. J.; Irtelli, L.; Wiest, G.; Monica, V.; Porcu, L.; Manegold, C.; Scagliotti, G. V. |